Although the medical relevance from the aforementioned cardiovascular hazard factor alterations by tirzepatide will likely be assessed within the planned cardiovascular consequence examine SURPASS-CVOT ( "kind":"medical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Examinati